[Other] CLO26-093: Real-World First-Line Atezolizumab每Bevacizumab Versus Durvalumab每Tremelimumab in Older Adults (≡65 Years) With Hepatocellular Carcinoma: A 1-Year Propensity-Matched Analysis

riazarrej Post time 1 hour(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-09-08 02:25
Reward20points

journalㄩJournal of the National Comprehensive Cancer Network

AuthorsㄩMadhu Bhargavi Chandra; Fayaz Khan; Madhu Babu Adusumilli; Zuhair Alam; Akshay Sridhar

Published dateㄩ2026-3-31

DOIㄩ10.6004/jnccn.2025.7383

PDF linkㄩhttps://jnccn.org/view/journals/ ... ticle-CLO26-093.xml

Article linkㄩhttps://doi.org/10.6004/jnccn.2025.7383

Article SourceㄩHarborside Press, LLC


Remarkㄩ
Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

You have to log in before you can reply Login | Register

Points Rules

Junior Member
  • post

  • reply

  • points

    0


Return to the list